Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System

ClinicalTrials.gov ID: NCT01401361

Public ClinicalTrials.gov record NCT01401361. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Evaluation of Contact™ Therapy™ Cool Path™ Cardiac Ablation System in Conjunction With EnSite Velocity Contact™ Technology for the Treatment of Typical Atrial Flutter

Study identification

NCT ID
NCT01401361
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott Medical Devices
Industry
Enrollment
150 participants

Conditions and interventions

Interventions

  • Treatment Arm Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2011
Primary completion
Mar 31, 2012
Completion
Aug 31, 2012
Last update posted
Feb 14, 2019

2011 – 2012

United States locations

U.S. sites
19
U.S. states
14
U.S. cities
18
Facility City State ZIP Site status
Cardiology, P.C. Birmingham Alabama 35211
Aurora Denver Cardiology Denver Colorado 80012
Hartford Hospital Hartford Connecticut 06102
St. Vincent's Hospital Jacksonville Florida 32204
Emory University Hospital Atlanta Georgia 30322
University of Chicago Chicago Illinois 60637
Ochsner Medical Center New Orleans Louisiana 70121
New York University Langone Medical Center - Tisch Hospital New York New York 10016
University of Rochester Rochester New York 14642
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599
Presbyterian Hospital Charlotte North Carolina 28204
Ohio Health Research Institute - GMC Columbus Ohio 43215
Providence St. Vincent Medical Center Portland Oregon 97225
Doylestown Hospital Doylestown Pennsylvania 18901
Texas Health Research & Education Institute Dallas Texas 75231
Memorial Hermann Hospital Houston Texas 77030
St. Luke's Episcopal Hospital Houston Texas 77030
Scott & White Memorial Hospital Temple Texas 76508
Virginia Cardiovascular Specialists Richmond Virginia 23229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01401361, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 14, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01401361 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →